Skip to content
6-K

Foreign Interim / Material

CureVac N.V.

0001410578-24-001884

← back to feed
Filed
Nov 12, 2024 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted Q3 2024 · Sep 30, 2024 224.33M sh
Shares Diluted Q3 2024 · Sep 30, 2024 224.31M sh
Shares Diluted Q3 2024 · Sep 30, 2023 223.91M sh
Shares Diluted Q3 2024 · Sep 30, 2023 219.78M sh
Operating Cash Flow Q3 2024 · Sep 30, 2024 €168.41M
Operating Cash Flow restated Q3 2024 · Sep 30, 2023 −€224.28M
Cash And Equivalents Q3 2024 · Sep 30, 2024 €550.86M
Cash And Equivalents Q3 2024 · Dec 31, 2023 €402.45M
Cash And Equivalents Q3 2024 · Sep 30, 2023 €464.15M
Cash And Equivalents Q3 2024 · Dec 31, 2022 €495.8M
Stockholders Equity Q3 2024 · Sep 30, 2024 €724.7M
Stockholders Equity Q3 2024 · Dec 31, 2023 €516.94M
Stockholders Equity Q3 2024 · Sep 30, 2023 €602.27M
Stockholders Equity Q3 2024 · Dec 31, 2022 €533.25M
Current Liabilities Q3 2024 · Sep 30, 2024 €94.35M
Current Liabilities Q3 2024 · Dec 31, 2023 €186.39M
Total Liabilities Q3 2024 · Sep 30, 2024 €129.49M
Total Liabilities Q3 2024 · Dec 31, 2023 €271.31M
Current Assets Q3 2024 · Sep 30, 2024 €584.72M
Current Assets Q3 2024 · Dec 31, 2023 €478.38M
Total Assets Q3 2024 · Sep 30, 2024 €854.19M
Total Assets Q3 2024 · Dec 31, 2023 €788.25M
Eps Diluted Q3 2024 · Sep 30, 2024 €1.50
Eps Diluted Q3 2024 · Sep 30, 2024 €0.86
Eps Diluted Q3 2024 · Sep 30, 2023 −€0.22
Eps Diluted Q3 2024 · Sep 30, 2023 −€0.79
Eps Basic Q3 2024 · Sep 30, 2024 €1.51
Eps Basic Q3 2024 · Sep 30, 2024 €0.87
Eps Basic Q3 2024 · Sep 30, 2023 −€0.22
Eps Basic Q3 2024 · Sep 30, 2023 −€0.79
Rd Expense Q3 2024 · Sep 30, 2024 €49.98M
Rd Expense Q3 2024 · Sep 30, 2024 €108.9M
Rd Expense Q3 2024 · Sep 30, 2023 €27.25M
Rd Expense Q3 2024 · Sep 30, 2023 €82.36M
Net Income Q3 2024 · Sep 30, 2024 €338.04M
Net Income Q3 2024 · Sep 30, 2024 €194.95M
Net Income Q3 2024 · Sep 30, 2023 −€48.68M
Net Income Q3 2024 · Sep 30, 2023 −€173.51M
Operating Income Q3 2024 · Sep 30, 2024 €368.38M
Operating Income Q3 2024 · Sep 30, 2024 €221.44M
Operating Income Q3 2024 · Sep 30, 2023 −€54.04M
Operating Income Q3 2024 · Sep 30, 2023 −€186.19M
Cost Of Revenue Q3 2024 · Sep 30, 2024 €21.93M
Cost Of Revenue Q3 2024 · Sep 30, 2024 €104.34M
Cost Of Revenue Q3 2024 · Sep 30, 2023 €24.28M
Cost Of Revenue Q3 2024 · Sep 30, 2023 €70.77M